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are derived, all OAT hospitals are instructed to screen all MI patients for one-month. Data 
are entered into a screening log, regardless of ekgfbtkty for the trial. 
Results: As of 01/31/02, 1835 MI patients (mean age 64 years) were logged tn 53 cen- 
ters in the US, 20 in Canada, and 30 in other countries. Of these, 69% wefa men and 
66% were white. EF was ~50% in 51%. ST elevation Ml (STEMI) was present in 60%. 
Patients with STEMI were younger (63 vs. 66 yean, p < O.OOOl), more likely to be male 
(73% vs 64%, p = 0.0006) and to have an EF < 50% (54% vs 46%, p = 0.012) compared 
to non-STEM1 patients. Coronary angiography occurred more frequently fn STEMI 
pateints (82% vs 66%; p < 0.0001) and more STEMI patients underwent PCI (56% vs 
36%, p < 0.0001). In the US, angiography was more likely to be performed in STEMI 
patients (66%) than in Canada (79%) and other countries (77%); p = 0.002). Reperfusion 
strategies were different tn STEMI patients with 46% of US patients undergoing primary 
PCI compared to 33% in Canada and 32% in other countries (p -z 0.0001). Thrombolysis 
was more frequent in non-US sites (52% in Canada and 49% in other countries) com- 
pared with only 30% of US patients (p < 0.0001). 
Conclusions: In hospitals participating I” OAT, 60% of patients presented with STEMI 
and the majority of these undergo angiography post-MI. In hospitals selected to partici- 
pate in OAT, thrombolysis is shll the predominant mode of reperfusion outside the US 
and primary PCI is the dominant strategy in the US. 
Gr2 and 3 Grl pts had complete resolution of chest pain. Relief of symptoms occurred 6 
to 36 months after baseline assessment. One Grl pt developed myocardial infarction. 
The remaining 13 Grl pts continued to have chest pain. SPECT became negative in 3117 
Grl and 23/25 GR pts. 37 pts (16/17 Grl and 21/25 GR) underwent repeat angiography 
at 10 year follow-up. Thirteen Grl pts had developed CAD as opposed to none of the GR 
pts. Conclusions (1) In women with angiographically normal appearing coronary arter- 
ies, persistence of chest pain over the years often relates to the development of CAD. (2) 
lntracoronaty acetylcholine testing may predict evolution toward CAD in a substantial 
portion of them. (3) Positive testing could be due to endothelial dysfunction preceding 
angiographically visible atherosclerosis. 
1148-90 lschemia During Daily Activities Is Associated With 
Impaired Endothelium-Dependent and Endothelium- 
independent Srachial Artery Dilation in Patients With 
Chronic Coronary Artery Disease 
1147-99 In-Hospital and One-Year Outcomes According to ST- 
Myocardial infarction Treated With Primary Angioplasty 
Segment Resolution in High-Risk Patients With Acute 
or Thrombolvsis: Data From the MISTRAL Studv 
Alan L. Hinderliter, Andrew Sherwood, Simon Bacon, Lana Watkins, Roben Waugh, 
James Blumenthal, Unfversity of North Carolina, Chapel Hill, NC 
Background: Impaired funchon of the vascular endothelium 01 blunted vasodilatoty 
electrocardiographic (ECG) monitoring would be characterized by diminished endothe- 
responses to nitric oxide may favor the occurrence of myocardial ischemia due to 
increased coronary vessel tone during daily activities in patients with chronic coronary 
artery disease. We hvpothesized that patients with ST deoression durino ambulatotv 
lium-deoendent and/or endothelium-indeoendent dilation of the brachlal atterv. 
Giuseppe Steffenino, Claudia Bruna, Guido Rossetti, Antonello Vado, Endrj Menardi, 
Lucilla Riva, Donata Lucci, Aldo P. Maggioni, on behalf of MISTRAL Investigators. 
ANMCO Research Center, Florence, Italy 
Background Resolution of ST elevation by >=70% (ST_RES) has been shown to predict 
acute outcome in selected patients (pts) with acute myocardial infarction (Ml) in trials of 
thrombolisis (TT) or primary angioplasty (P_PTCA). We studied the correlation of 
ST_RES after TT or P_PTCA, with the acute and l-year outcomes of high-risk Ml pts 
included in a multicentre. prospective observation in the community setting. 
Methods 2227 pts with high-risk ST-elevation Ml (with1 or> of the following characteris- 
tics: female/diabetic >70 y, z-4 leads with ST deviation, prewous Q-wave MI. signs of 
pump failure) < 12 h, were recruited at 47 centers: 1811 pts received TT or P_PTCA, and 
in 1045 (58%) of these, ST_RES at the end of reperfusion treatment with TT (683) or 
P_PTCA (362) could be evaluated. 
Results Death, shock or sevete head failure during hospital stay (ACUTE_D/HF), and 
death or ssvere heart failure at l-year (l-Y_D/HF) were similar after TT and P_PTCA. 
and occurred in 9.9% and 16.0% of these 1045 pts, respectively, vs 19.5% and 23.0% tn 
766 pts with unavailable ST_RES data (pcO.002). ST_RES was observed in 37.1% of 
pts, and was similar after TT (36.6%) and after P_PTCA (36.1%). ACUTE_D/HF 
occurred in 5.9% of pts with vs 12.2 without ST_RES (p 0.001). l-Y_D/HF occurred I” 
11.6% of pts with vs 18.6% of pts without ST_RES (p 0.003). At logistic regression anal- 
ysis, absence of ST_RES was significantly associated with ACUTE_D/HF (OR 2.5, 95% 
Cl 1.4-4.3). as were age, heart rate, systolic blood pressure and Killip class on admis- 
sion. Absence of ST_RES was also significantly associated with I-Y_D/HF (OR 1.6, 95% 
Cl 1.1 - 2.5). as were the above mentioned variables on admission, anterior vs nonante- 
rior MI, and previous Ml. 
Conclusion Our observational data in a large cohort of pts with high-risk MI in the com- 
munity setting confirm that ST_RES after reperfusion treatment with either TT or 
PPPTCA is a predictor of both acute and long-term mortality and heart failure. 
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1148-89 From Syndrome X to Coronary Artery Disease 
Olivia Manfrini, Alberico Borghi, Gianluigi Morgagni, Carmine Plzzi. Raffaele Buaiardini. 
University of Bologna, Bologna, Italy 
Background. Prognosis of middle-aged women with chest pain and angiographically 
normal coronary arteries (syndrome X: Sx) is believed to be totally benign. Previous stud- 
ies, however. did not account for the decade 01 so delay in development of coronary 
artery disease that women may experience. 
Methods. This study assessed the long-term follow-up (> 10 years) of 42 women with Sx 
(mean age at enrollment: 51 years). Diagnosis of Sx was based on clinical symptoms, 
evidence of reversible myocardial perfusion defects on thallium scan (SPECT) and nor- 
mal coronary angiogiography. At recruitment, all pts underwent intracoronary acetylcho- 
line testing (30 micrograms/minute for 2 minutes) during catheterization. Pts were 
followed-up at regular intervals (6 to 12 months). They all underwent SPECT and lipid 
profile every year. Coronary angiography was offered to pts after lo-year follow-up. 
Results. At recruitment, 17 pts developed chest pain and ECG changes during acetyl- 
choline in absence of identifiable comaiy spasm (Grl). The remaining 25 were free of 
ischemia during achetycholine testing (GR). All pts initally had normal lipid profiles. At 
the end of follow-up high cholesterol values were found in 9 pts (6 Grl and 3 Gr2). All 
Methods Following withdrawal of anti-ischemic medications, 63 patients with chronic 
coronary artery disease and evidence of exercise-induced ischemia underwent 1) ambu- 
latory ECG monitoring for 46 hours, 2) measurement of flow-mediated dilation of the bra- 
chtal artery, ah index of endothelial function, and 3) measurement of brachial artery 
dilation in response to nitroglycerin, an endothelium-independent vasodilator. Ah episode 
of ischemia during ECG monitoring was deftned as > lmm ST depression for > 1 minute, 
Flow-mediated dilation of the brachial artery was measured by high-frequency ultrasound 
and expressed as the percentage Increase in vessel diameter in response to hyperemia 
induced by 5 minutes of forearm Ischemia. Nitroglycerin-induced dilation was calculated 
as the percentage increase in diameter in response to 0.4 mg sublingual nitroglycerin. 
Results The 63 patients consisted of 43 men and 20 woman who averaged 64 f 11 
years of age. lschemia during ambulatory monitoring was observed in 17 patients. Flow- 
mediated dilation, corrected for vessel size. averaaed 3.1 f 1.1% in those with davtime 
ischemia and 5.9 * 0.6% in those without ST depression during ECG monitoring (p= 
0.025). Brachial anew dilation in resoonse to nitroolvcehn was also imoaired in oatients 
with ischemia during dally activities (11.9 f 1.6% vs 16.2 * 1 .O%, p=O.O24). There was 
no significant difference between the 2 groups in age, gender, or body size. 
Conclusions: These data suggest that impaired endothelium-dependent and endothe- 
lium-independent vasodilation may be important in the pathogenests of ischemia during 
daily activities in patients with chronic ischemic heart disease. 
1148-91 Ranolarine Increases Exercise Performance and 
Decreases Hemoglobin AlC in Angina Patients With 
Diabetes 
Bernard R. Chaitman, Sandra Skettino, Carl J. Pepine, John 0. Parker, Jaroslav Skopal, 
Galina Chumakova, Jerry Kuch, Whedy Wang, Andrew A. Wolff, St. Louis University 
School of Medicine, St. Louis, MO 
Background: Ranolazine (RAN), a partial fatty acid oxidation inhibitor, improves exer- 
cise capacity in pts with chronic angina when added to background antianginal therapy. 
The impact of RAN in diabetics (D) is of interest because approximately one in four 
angina pts has diabetes. 
Methods: CARISA randomized 623 symptomatic chronic angina pts on dilttazem, 
atenolol or amlodipine to RAN 750 mg bid, 1000 mg bid or placebo in a parallel, double- 
blind, 12.week study. Modified Bruce treadmill tests were pefformed at baseline, and 
after 2. 6, and 12 wks of treatment at trough and peak plasma levels. 
Results: RAN prolonged exercise duration (ED) similarly in both D and nondiabetics 
(ND) at trough and peak (table); time to angina increased oh RAN and angina frequency 
decreased (not shown). The improvement with RAN was not significantly different in D 
vs. ND pts (treatment by diabetes interaction p-values 20.26). Adverse events were simi- 
lar; 25%, 25% and 34% of D had at least one adverse event on placebo, 750 mg and 
1000 mg. respectively vs. 27%, 33% and 32% in ND pts. RAN 750 and 1000 mg bid were 
associated with an average absolute reduction in HbAlc of 0.46%age points and 
0.70%age points, respectively compared to placebo at 12 weeks (pcO.01). The reduc- 
tlons were greater in those pts on insulin (0.6 and l.l%age points, respectively). 
Conclusion: Ranolazine has similar antianginal effects in diabetics and non-diabetics 
who remain symptomatic using a beta blocker 01 calcium antagonist with favorable 
effects on glycemic control. 
Change from Baseline in ED: LS RAN 750 mg bid vs RAN 1000 mg bid vs 
mean (set) Placebo Placebo 
Trough’ Peak” Trough’ Peak” 
Diabetics (n=163) 29 34 34 44 
Non-diabetics (n=606) 22 35 21 21 
‘treatment by diabetes interaction p-value = 0.69; “treatment by diabetes 
Interaction p-value = 0.56 
